ACADEMIA

• Japan Cancer Association to Release Statement on Health Spending at Sept. Meeting
  August 24, 2018

• Only 30% of Patients Took Thyroid Tests before Receiving Dementia Meds: Survey
  July 25, 2018

• Debut of siRNA Therapeutic Looming on Horizon; Alnylam’s Patisiran Might Be Filed in Japan Too
  July 24, 2018

• Japanese Society of Medical Oncology to Update I/O Guidelines in October
  July 18, 2018

• Hematologist Optimistic about New Drugs for AML Including SMO and BCL-2 Inhibitors as Well as FLT3 Inhibitors
  July 11, 2018

• Doctors Need Solid Understanding of Hereditary Cancer When Prescribing Lynparza for Breast Cancer: Prof.
  July 5, 2018

• Anti-TNF-α Antibody Treatment for Crohn’s Disease Costs 1.95 Million Yen per Patient Annually: Study
  June 27, 2018

• Licensee Selection Draws Near for AMED-Backed Cancer Mouth Sores Treatment
  June 26, 2018

• Nucala, Fasenra to Be Ranked as Strongest Treatments in New Asthma Guidelines: Allergology Society
  June 21, 2018

• MHLW Study Group to Discuss Roles of JAK Inhibitors and Biosimilars toward RA Treatment Guidelines Revision
  June 5, 2018

• Nephrology Society to Issue New CKD Guidelines; Recommends Less-Strict Blood Pressure Management Target
  June 4, 2018

• AZ’s Durvalumab to Become New Treatment Option for Stage III NSCL Cancer: Oncologist
  May 28, 2018

• Breast Cancer Society Initiates Trial to Evaluate Efficacy of Denosumab at Increasing Bone Mass
  May 21, 2018

• Dupixent Used Generally as Adjunctive Therapy to Existing Treatments for Atopic Dermatitis: Dermatologist
  May 10, 2018

• 55 Anticancer Meds Available Overseas Unapproved in Japan, 3 Meds Costing over 10 Million Yen Monthly: NCC
  May 2, 2018

• New Guidelines Recommend LAMA as First-Line Bronchodilator for COPD: Respiratory Society
  April 24, 2018

• Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020
  April 23, 2018

• Expert Cautions against Hasty Discussions on Cost Effective Assessments
  April 20, 2018

• Biosimilar Use Essential to Sustain Universal Health Coverage: Society President
  April 19, 2018

• Physicians Association Initiates Large-Scale Study to Directly Compare DPP-4 Inhibitors to SGLT2 Inhibitors, Determine “Optimal Patients” for Each
  April 19, 2018

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »